Linda E. Klumpers

Brief Treatment With the Glucocorticoid Receptor Antagonist Mifepristone Normalises the Corticosterone‐Induced Reduction of Adult Hippocampal Neurogenesis

Joseph L. Mayer, Linda E. Klumpers, Suharti Maslam et al. · Journal of Neuroendocrinology · 2006 · 179 citations

Medicine, Neuroscience, Pharmacology +17

Manipulating brain connectivity with δ9-tetrahydrocannabinol: A pharmacological resting state FMRI study

Linda E. Klumpers, David M. Cole, Najmeh Khalili‐Mahani et al. · NeuroImage · 2012 · 96 citations

Life Sciences, Neuroscience, Pharmacology +13

Population Pharmacokinetic Model of THC Integrates Oral, Intravenous, and Pulmonary Dosing and Characterizes Short- and Long-term Pharmacokinetics

Jules A. A. C. Heuberger, Zheng Guan, Olubukayo‐Opeyemi Oyetayo et al. · Clinical Pharmacokinetics · 2014 · 78 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Novel Δ⁹‐tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects

Linda E. Klumpers, Tim L. Beumer, J. G. Coen van Hasselt et al. · British Journal of Clinical Pharmacology · 2012 · 77 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Peripheral selectivity of the novel cannabinoid receptor antagonist <scp>TM</scp>38837 in healthy subjects

Linda E. Klumpers, Marianne Fridberg, Marieke L. de Kam et al. · British Journal of Clinical Pharmacology · 2013 · 75 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14